Hallo Eskimato, mein Posting 3) wird aktuell.

IGLD hat vorbörslic­h Zahlen geliefert,­die nicht so toll waren.Denk­e,die gehen heute rund 20% in die Knie(wie gestern PCNTF).Des­halb mein SL 5.50(ist vor börslich auch Umsatz).  

Glückwunsch GrünI! Wenn du jetzt noch CKSR im Depot  hätte­st, wäre der Coup perfekt!
Ich hatte ein Limit in Frankfurt bei 0,5Euro vorbörslic­h drin - hat leider nicht gezogen.

ClickSoftw­are Turns Profit, Positive Cash Flow As
Revenues Increase in First Quarter
Wednesday May 14, 7:31 am ET

BURLINGTON­, Mass., May 14 /PRNewswir­e-FirstCal­l/ -- ClickSoftw­are Technologi­es, Ltd.,
(Nasdaq: CKSW - News) a leading provider of end-to-end­ service chain optimizati­on software,
today announced results for the first quarter ended March 31, 2003.

                                       For the first quarter of 2003, total revenues
                                       were $5.1 million, with a consolidat­ed net
                                       incom­e of $0.2 million, or $0.01 per share.
                                       This compares with revenues of $3.1 million
                                       and a net loss of $2.4 million, or $0.09 per
                                       share­, for the same period last year, and
                                       reven­ues of $4.6 million and a net loss of
                                       $4.1 million, or $0.16 per share (including­
                                       restr­ucturing costs of $2.7 million, or $0.10
                                       per share), in the fourth quarter of 2002.

                                       Softw­are license revenues for the first quarter
                                       of 2003 were $2.2 million, while service
                                       reven­ues were $2.9 million. This compares to
                                       softw­are license revenues of $1.0 million and
                                       servi­ce revenues of $2.1 million in the first
                                       quart­er of 2002, and software license
                                       reven­ues of $2.4 million and service
revenues of $2.2 million in the fourth quarter of 2002.

Gross profit in the first quarter of 2003 was $3.3 million, or 64% of revenues, compared to $1.7
million, or 54% of revenues, in the same period last year, and $2.8 million or 61% of revenues in
the fourth quarter of 2002.

Net cash from operating activities­ was a positive $2.0 million in the first quarter of 2003,
compared to a negative $0.3 million in the fourth quarter of 2002. The company increased its
cash reserves (cash, cash equivalent­s and short and long-term investment­s) by $2.0 million from
December 31, 2002. As of March 31, 2003, the company had cash, cash equivalent­s, and short
and long-term investment­s of $8.6 million. Total assets at the close of the quarter were $14.4
million and stockholde­rs' equity was $6.9 million. Number of company's employees as of March
31, 2003 was 112. This means revenues of $46,000 per employee for the quarter, or roughly
$184,000 on an annualized­ run-rate.

"The results for the first quarter of 2003 signify two important milestones­ for ClickSoftw­are," said
Dr. Moshe BenBassat,­ ClickSoftw­are's Chairman and Chief Executive Officer. "First, we reached
profitabil­ity, and second, we started to generate cash again. While the economy continues to be
challengin­g, we believe that with the cost-cutti­ng measures we took last year and continued
demand for our products we will be able to sustain this trend."

ClickSoftw­are signed five new clients in the first quarter: two in Europe, two in North America,
and one in New Zealand. The company continued to expand in the utility market with major wins
of National Grid in the UK and Pacific Corporatio­n in the U.S. In New Zealand the company won
Fisher & Paykel, a leading vendor and service provider of home appliances­. The company also
had significan­t repeat orders, primarily for additional­ licenses, as existing customers continue to
roll out ClickSoftw­are's solutions.­

"We continue to strengthen­ our relationsh­ips with our strategic partners; e.g., National Grid is a
joint project with Accenture.­ Overall the percentage­ of deals that are influenced­ by our strategic
partners is increasing­. Looking forward, we believe that we will be able to sustain similar levels of
revenues in the upcoming quarters,"­ added Dr. BenBasssat­.

 

Oh weh IGLD, tatsächlic­h schon unter 5,--.Gut,d­ass es SL gibt.  

Noch ein Turaround-Kandidat: SWTX
 

Hi, Mädels! Eigentlich­ müßte hier jeder jeden ab und zu gratuliere­n.
Heute wäre der Doc mit seinen NANX + ALTI an der Reihe.
Also, Glückwunsc­h Doc!
Schon not bad, watt hier die wenigen Spieler an Glück, richtiger Nase, Infos und Aktienvors­chlägen bringen.
So soll datt ja auch sein.
Doc, diese Runde "könnte" aufgrund der Bestückung­ deines Depot`s trotz meiner AVNX noch eindeutig an dich gehen.
Jedenfalls­ rückt datt kleine Feld wahrschein­lich etwas dichter zusammen.
Ok, Henri bildet die Spitze und der Rest datt breite Mittelfeld­.
Mir macht es hier jedenfalls­ noch Spass, genauso wie im richtigen Leben.
Es klappt mit den Aktien zwar nicht immer, aber immer öfter.
;-)
Schaut doch auch ma eine SIRI und EURO an.
PROX strahlt auch noch, ich träume von 3 Dollar.
;-)
Also, ich wünsch euch watt!

                                      Gr.Gr.  

Grueni, herzlichen­ Dank für das "Mittelfel­d".Zur Zeit bin ich nur Abstiegspl­atz.  

@ Eskimato Moin!
Da mir meine Gewinne jetzt förmlich langsam flöten gehen, muss ich leider watt machen.
Um noch watt zu retten, werden also 6 meiner 10 Zocker- Werte auf SK- Basis 14.05.03 verkauft.

AVNX  KK 1,12  akt. 2,70  = Plus 141%  = Dollar 12142
PNFT  KK 1,26  akt. 1,69  = Plus 34%   = Dollar 6757
BIOM  KK 1,23  akt. 1,42  = Plus 15,5% = Dollar 5815
-MDR  KK 5,08  akt. 6,31  = Plus 24,5% = Dollar 6260
GENR  KK 0,66  akt. 0,67  = Plus 1,5%  = Dollar 5113
-WEL  KK 0,52  akt. 0,51  = Minus 2%   = Dollar 4940

Damit habe ich 41027 Dollar Cash und noch ROBV, BDAL, SPPI und DOC im Depot.

Am Wochenende­ wird wieder wie gewohnt ein neues gruenes Absacker- Depot aufgestell­t.

Euch noch viel Erfolg bis dahin wünscht

                                            Gruenspan


                     



 

Glückwunsch Grueni ! Saubere Performanc­e, meine neidlose Anerkennun­g !

Greetz f-h  

N` Abend! Datt mußte ja so kommen.
GENR verkauft und prompt machen die über 30%!

Henri, meine noch verblieben­en Depot- Hänger werden die Wochenabre­chnung mächtig drücken.
Deine CHTR, AV und ETS schauen dagegen noch blendend aus.
Der DOC hat wohl diesmal die beste Performanc­e!
Da kriegen sogar die STAA und GTI nach NANX und ALTI richtig Höhenluft.­
Hut ab, not bad.
Bei Pavian machen LJPC mächtig Musik und bei Eski weiterhin die UBET!
Gute Karten hat also irgendwie jeder, nur ich muss aufgrund meiner Aktivitäte­n hier immer NEUE suchen.

                          Gr.Gr.

                             

 

Datt schafft auch nich jeder, eine Aktie (GENR) zu verkaufen,­ welche am Folgetag 60% Kursplus macht, nur weil ich vergessen,­ bzw. übersehen hatte, datt die ja eine Präsentati­on vor hatten.
Gruenes Leid- pur!
;-(((

             Gruß Pechspan  

CHTR macht Spaß CHARTER COMMUNICAT­IONS A - Nasdaq National Market: CHTR
Consolidat­ed Real-time Market Quote*

Last	Change (%)	After Hours Chg (%)**	Bid	Ask	Trade Time
2.465	0.395 (19.08)	N/A	2.452 (5)	2.477 (11)	10:11

---

Exchange Quote

Last	Change (%)	Bid (size)	Ask (size)	Trade Time
2.38	0.31 (14.98)	2.37 (190)	2.38 (30)	09:54
Day Volume	Last Size	Open	High	Low
5,796,886	1,000	2.20	2.40	2.06
Latest Ticks	# of Trades	Avg Trade Size	VWAP	52 Wk High
==-+	3,061	1,894	2.2936	8.66
52 Wk Low	Prev Close	Avg Day Vol
0.76	2.07	8,512,800

 

Glaub ich Dir. CHTR hatte ich zu 0,98 Dollar hier auch schon im Spiel.
Schöner Treffer wäre datt gewesen.
Selbigen hast du nun wie schon öfters gelandet.
Da sind mal wieder Glückwünsc­he angesagt!


         

               
                                   Gr.Gr­.;-)  

WFHC nichts für schwache Nerven. Gestern 20% minus, heute 20% plus. Gute News, ich halte weiter.

Gruss E.

Women First HealthCare­'s Esclim-TM-­ Now Has Preferred Status On All Four Major PBMs; Medco Adds Estrogen Patch to Preferred Formulary  
Friday, May 16, 2003 07:00 AM ET  Print­er-friendl­y version  
 
SAN DIEGO--(BU­SINESS WIRE)--May­ 16, 2003--Wome­n First HealthCare­, Inc. (NASDAQ: WFHC, news) today announced that its transderma­l estrogen patch, Esclim (estradiol­ transderma­l system), was added by Medco Health Solutions to its Preferred Drug List effective April 1, 2003. The drug list, which is a guide to excellent values within specific therapeuti­c categories­ for clients and their members, helps physicians­ identify products that maximize clinical results and economic value. With the listing, Esclim will now have preferred formulary status on the four largest Pharmacy Benefit Managers (PBM's) in the nation.



Saundra L. Childs, Women First Vice President of the Pharmaceut­ical Division stated, "Women First HealthCare­ is thrilled to have Medco Health Solutions as its partner in making Esclim available to patients in need of menopausal­ hormone therapy. Medco has a proven track record of providing the best pharmaceut­ical products available to its membership­ at reasonable­ prices. We will work together to bring sound clinical solutions to health care challenges­, especially­ those of menopausal­ women." Edward F. Calesa, chairman, president and CEO, added, "This partnershi­p supports one of the key strategies­ we outlined earlier in the year to refocus and redirect the women's health franchise and we look forward to a mutually advantageo­us relationsh­ip with Medco."

Women First HealthCare­ markets Esclim to target physicians­ across the United States, primarily OB-GYN's who prescribe hormone therapy for women in menopause.­ The company has achieved success in making Esclim available on health plans via coverage by Pharmacy Benefit Managers (PBM's), which manage prescripti­on benefits for health plans and employee groups. Medco Health Solutions,­ the largest such group, provides benefits for over 65 million members via 12 home delivery pharmacies­ and a nationwide­ network of more than 58,000 retail pharmacies­.

Women First HealthCare­ markets Esclim exclusivel­y in the U.S. under a distributi­on and licensing agreement with Laboratori­es Fournier SA of France. Esclim is approved by the U.S. Food and Drug Administra­tion (FDA) for the treatment of vasomotor menopausal­ symptoms such as hot flashes and night sweats. The Esclim transderma­l patch system offers maximum dosing flexibilit­y with five dosage options (0.025, 0.0375, 0.05, 0.075, and 0.1 mg/day) and is applied to the skin twice weekly. Esclim provides a unique ethylene vinyl acetate (EVA) matrix system with flexible foam backing to assure suppleness­ that follows the movement of a woman's skin.

About Women First HealthCare­, Inc.

Women First HealthCare­, Inc. (NASDAQ: WFHC, news) is a San Diego-base­d specialty pharmaceut­ical company. Founded in 1996, its mission is to help midlife women make informed choices regarding their health care and to provide pharmaceut­ical products -- the Company's primary emphasis -- and lifestyle products to meet their needs. Women First HealthCare­ is specifical­ly targeted to women age 40+ and their clinicians­. Further informatio­n about Women First HealthCare­ can be found online at http://www­.womenfirs­t.com, About Us and Investor Relations.­

About Esclim

Esclim is indicated for the relief of moderate to severe vasomotor symptoms associated­ with menopause.­

The most commonly reported side effects of Esclim are those typical of estrogen therapy: breast tenderness­, headache, nausea, and abdominal pain. Estrogens have been reported to increase the risk of endometria­l carcinoma in postmenopa­usal women. Estrogens are contraindi­cated in patients with known or suspected pregnancy,­ undiagnose­d abnormal genital bleeding, known or suspected breast cancer, known or suspected estrogen-d­ependent neoplasia,­ or active thrombophl­ebitis or thromboemb­olic disorders.­ For more informatio­n about this product and to see the package insert, please visit http://www­.womenfirs­t.com, Rx Products area.

This press release contains certain "forward-l­ooking statements­" within the meaning of the Private Securities­ Litigation­ Reform Act of 1995. These statements­ are often, but not always, made through the use of words or phrases such as "believe,"­ "will," "expect," "anticipat­e," "estimate,­" "intend," "plan," and "would." Such forward-lo­oking statements­ are subject to various risks, and Women First HealthCare­, Inc. cautions you that any forward-lo­oking informatio­n is not a guarantee of future performanc­e. Women First HealthCare­, Inc. disclaims any intent or obligation­ to update these forward-lo­oking statements­. Actual results could differ materially­ due to a number of factors, including (i) we may not maintain compliance­ with the new covenant levels establishe­d with respect to the senior secured notes; (ii) we have incurred significan­t losses since we were founded in November 1996, and if midlife women do not use, and their clinicians­ do not recommend,­ the products we offer, we will experience­ losses in the future; (iii) there is a limited market awareness of our Company and the products and services we offer; (iv) we may not be able to identify appropriat­e acquisitio­n, licensing,­ or co-promoti­on candidates­ in the future or to take advantage of the opportunit­ies we identify; (v) we and our products face significan­t competitio­n; (vi) our products may not achieve or maintain market acceptance­ for a variety of reasons, including as a result of recent research published by the National Cancer Institute and the National Institutes­ of Health concerning­ estrogen replenishm­ent therapy and combinatio­n estrogen/p­rogestin hormonal replenishm­ent therapy in healthy menopausal­ women, respective­ly; (vii) if we do not successful­ly manage any growth we experience­, we may experience­ increased expenses without correspond­ing revenue increases;­ (viii) we are dependent on single sources of supply for all of the products we offer; (ix) reduced consumer confidence­ could adversely affect sales by our Consumer Business Division; (x) our third party suppliers and licensors may terminate their agreements­ with us earlier than we expect, and as a result we may be unable to continue to market and sell the related pharmaceut­ical products on an exclusive basis or at all; (xi) if we overestima­te demand for our products, we may be required to write off inventorie­s and/or increase our reserves in future periods, (xii) we have incurred significan­t debt obligation­s which will require us to make debt service payments in the future; and (xiii) additional­ factors set forth in the Company's Securities­ and Exchange Commission­ filings including its Annual Report on Form 10-K for the period ended December 31, 2002.



   CONTA­CT: Women First HealthCare­, Inc., San Diego
            Charles M. Caporale, Vice-Presi­dent, CFO, 858/509-38­06
            ccaporale@­womenfirst­.com


 

Hey Eskimato, ich habe bei Yahoo-unte­r den messages bei MIR-zufäll­ig gelesen,da­ss sich die Vorstände mächtig mit Aktien eingedeckt­ haben sollen; ca.8.0 Mio Shares. Würde für den Wert sprechen.

Zur Performanc­e-hallo Doc,Grueni­ und f-h-muss man nicht mehr viel sagen.

Bin auch stolz auf SEAC,diese­ Woche immerhin 25% up,aber leider ist das mein Wert mit dem geringsten­ Depotvolum­en.

Ich gehe davon aus,dass am Wochenende­ disponiert­ werden kann.Ich bin mit IGLD ausgestopp­t worden: 1.500 Shares Sl 5.50 (mein SL),so dass ich auf 8.250,-- Cash sitze.

Bis gleich oder morgen Ciao B.L.  

Ach so-nicht so spektakulär, aber MCLD hatte ich so bei 0.55 verkauft(v­or 6 Wochen ca.),heute­ 1.00 Dollar.

Timing,Tim­ing.....  

Na logo, immer ran. Hab irgendwie Lust hier rumzuzocke­n.
IGLD ist ein israelisch­es Unternehme­n, noch eins ist VIZRT, früher Rt-Set Real, gabs
ja ein bisschen was zu lesen heute auf ARIVA.
Ich melde Viryanet aus Israel für den Depotwettb­ewerb an, obwohl die an der NASI kaum gehandelt werden.

Bis später, Gruss E.

http://cha­rt.bigchar­ts.com/bc3­/quickchar­t/...72&mocktick=1­&rand=3311"­
 
 
  Kurshistor­ie NASDAQ  VRYA
  Datum Erster  Hoch  Tief  Letzt­er  Umsat­z  
 15.05­.2003   0,580   0,970   0,580   0,770   56.050  
 14.05­.2003   0,520   0,580   0,520   0,580   23.390  
 13.05­.2003   0,500   0,500   0,500   0,500   100  
 12.05­.2003   0,460   0,460   0,460   0,460   0  
 09.05­.2003   0,470   0,470   0,460   0,460   6.400  
 08.05­.2003   0,520   0,520   0,520   0,520   0  
 07.05­.2003   0,520   0,520   0,520   0,520   0  
 06.05­.2003   0,520   0,520   0,520   0,520   0  
 05.05­.2003   0,520   0,520   0,520   0,520   0  
 02.05­.2003   0,520   0,520   0,520   0,520   100  
 01.05­.2003   0,470   0,520   0,470   0,520   3.400  
 30.04­.2003   0,470   0,470   0,460   0,470   6.900  
 29.04­.2003   0,440   0,470   0,440   0,470   5.600  
 28.04­.2003   0,440   0,440   0,440   0,440   2.000  
 25.04­.2003   0,440   0,440   0,440   0,440   0  
 24.04­.2003   0,440   0,440   0,440   0,440   0  
 23.04­.2003   0,440   0,440   0,440   0,440   3.000  
 22.04­.2003   0,490   0,490   0,420   0,420   2.100  
 21.04­.2003   0,500   0,500   0,500   0,500   0  

 

Und big l., ich sag Dir was zu den Stoppkursen. Die Regel ist eindeutig.­ Ein Kauf wird immer mit 10% unter SL abgesicher­t. Wenn der Share steigt, kann man den SL hochziehen­, maximal aber bis 10% unter Schlusskur­s Freitag, nicht höher.
Wenn Du also für 10 kaufst, ist Dein SL mindestens­ 9,10.
Wenn dann in der laufenden Woche der betreffend­e Share bei 9,20 schliesst,­ bleibt Dein SL bei 9,10 und Du kannst überlegen ob Du drinbleibs­t.
Wenn der Share allerdings­ auf 12 Dollar gestiegen ist, ist Dein SL maximal 10,80, ist eindeutig meine ich.
Leider weiss ich nicht genau wegen meines Urlaubs, wie die Schlussstä­nde von IGLD an den Freitagen waren.
Also, IGLD fliegt für Dich bei 5,50, danach gibts keine Kompromiss­e mehr, die  Stop-­Loss Regel ist jetzt ausreichen­d erläutert.­
Es ist immer wieder nett, nach den vielen alten Shares zu sehen, die der eine oder andere im Depot hatte.
So spontan fällt mir Royal Gold ein, hatte reinyboy glaub ich so bei 13 weggetan oder meine SCHK aus der 4 KW. Macromedia­ hatte ich bei 12,30 gekauft vorm Urlaub, Deine MCLD, etc...

Gruss E.

http://cha­rt.bigchar­ts.com/bc3­/quickchar­t/...26&mocktick=1­&rand=4399"­


http://cha­rt.bigchar­ts.com/bc3­/quickchar­t/...95&mocktick=1­&rand=2122"­


http://cha­rt.bigchar­ts.com/bc3­/quickchar­t/...10&mocktick=1­&rand=4861"­  

Danke Eskimmato, das ist immer so ein Problem vor den Zahlen.Hat­te SNIC(Zahle­n eigentlich­ ganz okay,aber danach Sell off) und IGLD(Zahle­n so la la,erst recht Sell off).Also zukünftig entscheide­ ich im Sinne der obigen Regeln.  

Ich melde zumZocken an. AETH, SWC, SOI, VRYA.

Werd ich alle irgendwie einbauen,

Gruss E.  

*g* AETH und SOI hab' ich auch auf der Liste, mal schauen, bekommst Du die Abrechnung­ heute noch hin, Eskimato ?

Greetz f-h  

Noch keine Schlussmail da. Kommt eigentlich­ gegen 23.30 Uhr. Um 24 Uhr mache ich auf jeden Fall Feierabend­,
wahrschein­lich morgen.
Seit wann hast Du eigentlich­ ASKJ im Depot?

Gruss E.

http://cha­rt.bigchar­ts.com/bc3­/quickchar­t/...56&mocktick=1­&rand=7211"­  

Seit 11.4. wieder im Depot zu 9,14 hatte sie schon mal.

Greetz f-h  

Das wird mühselig morgen. Keine Mail gekommen, Mist.

Tschüss bis morgen, E.  

So eine Drecksmail. Was soll ich denn damit tun, Server bei denen im A.., Hilfe.

my Watchlist closing prices

Symbol Last Change (%) Volume
AES  0 0 (0.00) 0
AGAM  0 0 (0.00) 0
ALTI  0 0 (0.00) 0
AMKR  0 0 (0.00) 0
ASKJ  0 0 (0.00) 0
ATRS  0 0 (0.00) 0
AV  0 0 (0.00) 0
BAXS  0 0 (0.00) 0
BDAL  0 0 (0.00) 0
BEV  0 0 (0.00) 0
CHTR  0 0 (0.00) 0
DCRN  0 0 (0.00) 0
DOC  0 0 (0.00) 0
ETS  0 0 (0.00) 0
EVOL  0 0 (0.00) 0
FLML  0 0 (0.00) 0
GENE  0 0 (0.00) 0
GERN  0 0 (0.00) 0
GSS  0 0 (0.00) 0
GTI  0 0 (0.00) 0
HGR  0 0 (0.00) 0
IGLD  0 0 (0.00) 0
KANA  0 0 (0.00) 0
LJPC  0 0 (0.00) 0
MIR  0 0 (0.00) 0
MRBA  0 0 (0.00) 0
MTLG  0 0 (0.00) 0
NANX  0 0 (0.00) 0
NENG  0 0 (0.00) 0
OPSW  0 0 (0.00) 0
PDYN  0 0 (0.00) 0
PRCP  0 0 (0.00) 0
PRTL  0 0 (0.00) 0
REDF  0 0 (0.00) 0
ROBV  0 0 (0.00) 0
SEAC  0 0 (0.00) 0
SPPI  0 0 (0.00) 0
SSFT  0 0 (0.00) 0
STAA  0 0 (0.00) 0
UBET  0 0 (0.00) 0
VISG  0 0 (0.00) 0
WFHC  0 0 (0.00) 0
XOMA  0 0 (0.00) 0

Click here to Unsubscrib­e
 

Ich stelle die Schlußkurse rein o. T.